BioSpace News Archive

GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.

Moleculin Biotech, Inc. today announced the formation of its Annamycin Scientific Advisory Board and inaugural appointment of Dr. Martin Tallman.

Oncternal Therapeutics, Inc. today announced the approval of an inducement award to one new employee, Anne C. Hansen, who is joining Oncternal as Senior Director, Clinical Data Management.

Cassava Sciences, Inc. has been advised by NASDAQ that end-of-day tomorrow May 2, 2024, will be the last and final trading day for SAVAW warrants on NASDAQ.

Bio-Rad Laboratories, Inc. today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 2:05 PM Eastern Time (11:05 AM Pacific Time).

GE HealthCare announced Revolution RT,i a new radiation therapy computed tomography solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.

Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.

Syra Health Corp. (NASDAQ: SYRA), (“Syra Health” or the “Company”) announced today that it will report financial results for its first quarter 2024 ended March 31, 2024, on Thursday, May 9, 2024, before the market opens.

Olympus announced the availability of the new DVM-B2 Digital Video Monitor, an all-in-one video processor and monitor for use with single-use endoscopes for both bronchoscopy and ENT including the H-SteriScope™ Single-use Flexible Bronchoscopes and the E-SteriScope™ Single-use Flexible Rhinolaryngoscopes.

Integer Holdings Corporation today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas.